Skip to main content
. 2014 Sep 22;211(10):2033–2045. doi: 10.1084/jem.20140039

Table 2.

Clinical manifestation of CVID patients

Subjects LPS Autoimmunity IBD Lymphoid hyperplasia Granulomatous disease
CVID-1 No No No Yes (intestinal) No
CVID-2 Yes No No No No
CVID-3 Yes No No No No
CVID-4 Yes No No No No
CVID-5 Yes Yes No Yes (intestinal) Yes
CVID-6 No No No No No
CVID-7 No No No No No
CVID-8 No No No No No
CVID-9 Yes Yes No No Yes
CVID-10 No No No No No
CVID-11 Yes No No Yes (intestinal) No
CVID-12 Yes Yes No No No
CVID-13 No Yes Yes Yes (intestinal) Yes
CVID-14 Yes Yes No No Yes
CVID-15 Yes Yes (diabetes) No Yes (intestinal) No
CVID-16 Yes No No Yes (intestinal) No
CVID-17 No No No Yes (intestinal) No
CVID-18 No No No Yes (intestinal) No
CVID-19 Yes No No Yes (intestinal) No
CVID-20 Yes No No Yes (intestinal) No
CVID-21 Yes No No Yes (intestinal) No
CVID-22 No No No Yes (intestinal) No
CVID-23 No No No Yes (intestinal) No
CVID-24 No No No Yes (intestinal) No
CVID-25 No No No Yes (intestinal) No
CVID-26 No Yes (diabetes) No Yes (intestinal) No